Skip to main content
. Author manuscript; available in PMC: 2023 May 30.
Published in final edited form as: Circulation. 2022 Aug 1;146(9):e119–e136. doi: 10.1161/CIR.0000000000001082
Reviewer Disclosures
Reviewer Employment Research grant Other research support Speakers’ bureau/honoraria Expert witness Ownership interest Consultant/advisory board Other
Martin R. Cowie Royal Brompton Hospital (United Kingdom) Abbott (Research Fellowship grant to my department) None Abbott*; Medtronic* None None AstraZeneca; Abbott*; Medtronic* None
Jose A. Joglar UT Southwestern Medical Center None None None None None None None
Chiadi Ndumele Johns Hopkins University None None None None None None None
Jean-Louis Pépin Centre Hospitalier Universitaire Sleep Laboratory and EFCR Grenoble University Hospital (France) None None None None None None None
Craig L. Phillips University of Sydney (Australia) None None None None None None None
This table represents the relationships of reviewers that may be perceived as actual or reasonably perceived conflicts of interest as reported on the Disclosure Questionnaire, which all reviewers are required to complete and submit. A relationship is considered to be “significant” if (a) the person receives $5000 or more during any 12-month period, or 5% or more of the person’s gross income; or (b) the person owns 5% or more of the voting stock or share of the entity, or owns $5000 or more of the fair market value of the entity. A relationship is considered to be “modest” if it is less than “significant” under the preceding definition.
*
Modest.
Significant.